4.4 Letter

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

Journal

HAEMATOLOGICA
Volume 99, Issue 6, Pages E81-E83

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2013.103085

Keywords

HLA-C binding KIR2D reports; KIR2D blockade; IPH2101; smoldering multiple myeloma; NK-cell function; clinical response

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available